NJ State Employees Deferred Compensation Plan - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 64 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
NJ State Employees Deferred Compensation Plan ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$8,940
+80.1%
30,0000.0%0.00%0.0%
Q2 2023$4,965
-83.0%
30,0000.0%0.00%
-80.0%
Q1 2023$29,280
-6.2%
30,0000.0%0.01%0.0%
Q4 2022$31,200
-10.9%
30,0000.0%0.01%
-16.7%
Q3 2022$35,000
-37.5%
30,0000.0%0.01%
-33.3%
Q2 2022$56,000
-38.5%
30,0000.0%0.01%
-25.0%
Q1 2022$91,000
-19.5%
30,0000.0%0.01%
-14.3%
Q4 2021$113,000
-27.1%
30,0000.0%0.01%
-33.3%
Q3 2021$155,000
+34.8%
30,0000.0%0.02%
+40.0%
Q2 2021$115,000
+49.4%
30,0000.0%0.02%
+36.4%
Q1 2021$77,000
+2.7%
30,0000.0%0.01%
-8.3%
Q4 2020$75,000
+21.0%
30,0000.0%0.01%
+9.1%
Q3 2020$62,000
-33.3%
30,0000.0%0.01%
-35.3%
Q2 2020$93,000
+36.8%
30,0000.0%0.02%
+6.2%
Q1 2020$68,000
-37.6%
30,0000.0%0.02%
-15.8%
Q4 2019$109,000
+6.9%
30,0000.0%0.02%0.0%
Q3 2019$102,00030,0000.02%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Omega Fund Management, LLC 778,230$5,308,0005.22%
BVF INC/IL 3,592,549$24,501,0002.48%
Prosight Management, LP 563,763$3,845,0002.41%
SPHERA FUNDS MANAGEMENT LTD. 800,000$5,456,0000.83%
Virtus ETF Advisers LLC 125,695$857,0000.74%
EAM Investors, LLC 521,460$3,556,0000.59%
Tekla Capital Management LLC 2,087,380$14,236,0000.55%
Orbimed Advisors 5,550,000$37,851,0000.47%
EAM Global Investors LLC 125,635$857,0000.44%
Schonfeld Strategic Advisors LLC 830,637$5,665,0000.42%
View complete list of PIERIS PHARMACEUTICALS INC shareholders